EL7.AI
StocksMediumUpdated•Originally published 24 July 2026•Updated 24 July 2026•
1 min read

Tenet Healthcare and Lamb Weston Beat Estimates on Strong Revenue Growth

Key Facts

1Tenet Healthcare reported EPS of $6.12, significantly beating the $4.26 estimate, triggering a 23% stock price surge.
2Lamb Weston reported EPS of $0.87 and revenue of $1.77 billion, driven by robust volume growth in North America.

Reflecting the resilience of the healthcare and frozen food sectors amid economic shifts, Tenet Healthcare and Lamb Weston reported quarterly results that significantly exceeded analyst expectations. Tenet Healthcare posted an EPS of $6.12, far surpassing the $4.26 estimate and triggering a 23% surge in its stock price. Meanwhile, Lamb Weston achieved an EPS of $0.87 and revenue of $1.77 billion, supported by robust volume growth across its North American operations.

Tenet's performance was primarily driven by same-store revenue growth and disciplined expense management, strengthening its position against industry peers. Per market data, competitor HCA Healthcare (HCA) closed at $373.09 on July 21, 2026. Tenet Healthcare (THC) maintains a debt-to-equity ratio of 2.84, a key metric for investors monitoring how the hospital operator finances its extensive network of outpatient centers and facilities.

As of the close on July 22, 2026, THC stood at $195.35 while LW was priced at $48.00. Investors are now looking toward broader economic indicators for directional cues; recent data showed a 2.603 million barrel increase in API Crude Oil Stocks as of July 21, which may impact operational costs for energy-sensitive sectors in the coming weeks.